Literature DB >> 30644326

Dopamine manipulations drive changes in information sampling in healthy volunteers.

Raquel Vicario-Feliciano1, Rebekah L Wigton2, Thomas P White2,3, Sukhi S Shergill2, Bruno B Averbeck1.   

Abstract

BACKGROUND: Information sampling is the cognitive process of accumulating information before committing to a decision. Patients across numerous disorders show decreased information sampling relative to controls. AIMS: Here, we used the Beads and the Best Choice Tasks to study the role of dopamine signaling in information sampling.
METHODS: Participants were given placebo, amisulpride, or ropinirole in each session, in a double-blind cross-over design.
RESULTS: We found that ropinirole (agonist) increased the number of beads drawn in the Beads Task specifically when participants faced a loss, and decreased the rank of the chosen option in the Best Choice Task.
CONCLUSIONS: These effects are likely driven by a combination of effects at presynaptic D2 receptors, which affect dopamine release, and post-synaptic D2 receptors. Increased D2 relative to D1 receptor activation in the striatum leads to increased sampling in the loss condition in the Beads Task. It also leads to choice of a poorer ranked option in the Best Choice Task. Decreased D2 relative to D1 receptor activation leads to decreased sampling in the Beads Task in the loss condition.

Entities:  

Keywords:  Dopamine; information sampling; neural circuits; psychopharmacology

Mesh:

Substances:

Year:  2019        PMID: 30644326      PMCID: PMC6996051          DOI: 10.1177/0269881118822080

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  42 in total

1.  Incorrigibility, jumping to conclusions, and decision threshold in schizophrenia.

Authors:  Ruth Veckenstedt; Sarah Randjbar; Francesca Vitzthum; Birgit Hottenrott; Todd S Woodward; Steffen Moritz
Journal:  Cogn Neuropsychiatry       Date:  2011-01-25       Impact factor: 1.871

2.  Cognitive factors associated with subclinical delusional ideation in the general population.

Authors:  John Anthony Zawadzki; Todd Stephen Woodward; Helen Moriah Sokolowski; Heather Shirley Boon; Albert Hung Choy Wong; Mahesh Menon
Journal:  Psychiatry Res       Date:  2012-03-13       Impact factor: 3.222

3.  Impulse control disorders in Parkinson's disease: clinical characteristics and implications.

Authors:  Robert F Leeman; Marc N Potenza
Journal:  Neuropsychiatry (London)       Date:  2011-04

Review 4.  Focus on amisulpride.

Authors:  Ben Green
Journal:  Curr Med Res Opin       Date:  2002       Impact factor: 2.580

5.  Dopamine modulates novelty seeking behavior during decision making.

Authors:  Vincent D Costa; Valery L Tran; Janita Turchi; Bruno B Averbeck
Journal:  Behav Neurosci       Date:  2014-06-09       Impact factor: 1.912

6.  Dopamine agonists rather than deep brain stimulation cause reflection impulsivity in Parkinson's disease.

Authors:  Atbin Djamshidian; Sean S O'Sullivan; Thomas Foltynie; Iciar Aviles-Olmos; Patricia Limousin; Alastair Noyce; Ludvic Zrinzo; Andrew J Lees; Bruno B Averbeck
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

7.  The dopaminergic innervation of monkey prefrontal cortex: a tyrosine hydroxylase immunohistochemical study.

Authors:  D A Lewis; S L Foote; M Goldstein; J H Morrison
Journal:  Brain Res       Date:  1988-05-24       Impact factor: 3.252

8.  Dopaminergic modulation of probabilistic reasoning and overconfidence in errors: a double-blind study.

Authors:  Christina Andreou; Steffen Moritz; Kristina Veith; Ruth Veckenstedt; Dieter Naber
Journal:  Schizophr Bull       Date:  2013-05-09       Impact factor: 9.306

9.  Reflection impulsivity in current and former substance users.

Authors:  Luke Clark; Trevor W Robbins; Karen D Ersche; Barbara J Sahakian
Journal:  Biol Psychiatry       Date:  2006-01-31       Impact factor: 13.382

10.  Midbrain functional connectivity and ventral striatal dopamine D2-type receptors: link to impulsivity in methamphetamine users.

Authors:  M Kohno; K Okita; A M Morales; C L Robertson; A C Dean; D G Ghahremani; F W Sabb; R A Rawson; M A Mandelkern; R M Bilder; E D London
Journal:  Mol Psychiatry       Date:  2016-02-02       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.